3
Total investments
0
Early stage
0
Mid stage
0
Late stage
21y
Years active
Experience · 10 entries
All (10)
Investments (3)
Founder (1)
Board (2)
2022
Chief Executive Officer
Mar 2022
Orphazyme is a global biopharmaceutical company, headquartered in Denmark, with a rapidly growing presence in the United States. We are pioneering a new kind of treatment, applying our specialized expertise to bring innovative therapies to patients with neurodegenerative orphan diseases. With a late-stage drug pipeline, we are relentless in our commitment to advancing treatments and making a profound impact for those touched by these rare, serious diseases.
Today we are listed on Nasdaq Copenhagen (TICKER: ORPHA.CO) and Nasdaq U.S. (TICKER: ORPH), and are expanding our global presence with offices in Denmark, Switzerland, and our US headquarters in Chicago.
See our community guidelines: bit.ly/3uapRYr
2019
2016
O
Orphazyme A/S (public)
Chief Financial Officer
May 2016
2015
A
Alpha Healthcare Investments ApS
Partner
Jan 2015
2012
T
Topotarget A/S (public)
Chief Executive Officer
Aug 2012
Show all 10 entries ↓
Investment activity
2005–2019 · 3 investments
Recent (last 2 years)Earlier